Skip to main content

Deciphera Pharmaceuticals, Inc.

DCPHDelisted Jun 11, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001654151

Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Deciphera Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of DCPH: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders168147−21
Shares43.4M43.5M+115.2K (+0.3%)
Value$1.94B$1.58B−$364.0M (−18.7%)

New holders (11)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to DCPH in Q2 2021
InstitutionSharesValue% of portfolio
CIBC Asset Management Inc546,825$20.0M0.08%
Armistice Capital, LLC472,000$17.3M0.46%
HealthCor Management, L.P.386,190$14.1M0.58%
Point72 Asset Management, L.P.166,100$6.08M0.03%
AlphaCrest Capital Management LLC44,600$1.63M0.07%
Assenagon Asset Management S.A.25,974$951.0K0.00%
Boothbay Fund Management, LLC7,017$257.0K0.01%
Martingale Asset Management L P5,904$217.0K0.00%
Group One Trading, L.P.2,907$106.0K0.00%
Walleye Trading LLC2,722$100.0K0.00%
Simplex Trading, LLC1,720$62.0K0.00%

Sold out (32)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.